Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | GSR | P00390 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19207251 | 0.98 | TSHR (0.44) | TSHRCPB2CYP1A2POLBAPEX1 | |
| SCHEMBL19207299 | 0.98 | TSHR (0.44) | TSHRCPB2CYP1A2POLBAPEX1 | |
| SCHEMBL19207302 | 0.98 | TSHR (0.44) | TSHRCPB2CYP1A2POLBAPEX1 | |
| SCHEMBL19207268 | 0.98 | TSHR (0.44) | TSHRCPB2CYP1A2POLBAPEX1 | |
| SCHEMBL19207246 | 0.98 | TSHR (0.44) | TSHRCPB2CYP1A2POLBAPEX1 | |
| SCHEMBL446080 | 0.94 | TSHR (0.39) | TSHRCPB2CYP1A2POLBAPEX1 | |
| SCHEMBL41031 | 0.86 | TSHR (0.36) | TSHRTHRB | |
| Hydrochloric Acid SCHEMBL2533776 | 0.85 | TSHR (0.35) | TSHRTHRB | |
| Ammonia Solution, Strong SCHEMBL3663515 | 0.85 | TSHR (0.35) | TSHRTHRB | |
| SCHEMBL8414991 | 0.83 | TSHR (0.43) | TSHRPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190040172-A1 | AQUEOUS EMULSION POLYMERS AS RHEOLOGY MODIFIERS, COMPOSITIONS THEREOF, AND METHOD OF USE | ISP INVESTMENTS LLC (US) | 2019-02-07 | — | — | US | disclosed |
| EP-3411418-A1 | AQUEOUS EMULSION POLYMERS AS RHEOLOGY MODIFIERS, COMPOSITIONS THEREOF, AND METHOD OF USE | ISP Investments LLC (US) | 2018-12-12 | — | — | EP | disclosed |
| WO-2017136800-A1 | AQUEOUS EMULSION POLYMERS AS RHEOLOGY MODIFIERS, COMPOSITIONS THEREOF, AND METHOD OF USE | ISP INVESTMENTS LLC (US) | 2017-08-10 | — | — | WO | disclosed |
| EP-1765276-B1 | SHATTER RESISTANT ENCAPSULATED COLORANTS FOR NATURAL SKIN APPEARANCE | BASF SE (DE) | 2013-11-06 | — | — | EP | disclosed |
| EP-2276797-B1 | POLYMER ENCAPSULATED COLOURANTS BY SPRAY DRYING | BASF SE (DE) | 2012-11-21 | — | — | EP | disclosed |
| US-20120149265-A1 | PARTICULATE COMPOSITION | BASF SE (DE) | 2012-06-14 | — | — | US | disclosed |
| EP-2449050-A1 | PARTICULATE COMPOSITION | BASF SE (DE) | 2012-05-09 | — | — | EP | disclosed |
| US-20110147965-A1 | POLYMER ENCAPSULATED COLOURANTS BY SPRAY DRYING | BASF SE (DE) | 2011-06-23 | — | — | US | disclosed |
| US-7947294-B2 | Shatter resistant encapsulated colorants for natural skin appearance | BASF SE (DE) | 2011-05-24 | — | — | US | disclosed |
| EP-2276797-A1 | POLYMER ENCAPSULATED COLOURANTS BY SPRAY DRYING | BASF SE (DE) | 2011-01-26 | — | — | EP | disclosed |
| WO-2009135791-A1 | POLYMER ENCAPSULATED COLOURANTS BY SPRAY DRYING | BASF SE (DE) | 2009-11-12 | — | — | WO | disclosed |
| EP-2029090-A1 | BLEED-RESISTANT COLORED MICROPARTICLES | Ciba Holding Inc. (CH) | 2009-03-04 | — | — | EP | disclosed |
| EP-2029091-A2 | BLEED-RESISTANT COLORED MICROPARTICLES AND SKIN CARE COMPOSITIONS COMPRISING THEM | The Procter and Gamble Company (US) | 2009-03-04 | — | — | EP | disclosed |
| US-20070287789-A1 | Bleed-resistant colored microparticles | CIBA SPECIALTY CHEMICALS CORP. | 2007-12-13 | — | — | US | disclosed |
| WO-2007141742-A2 | BLEED-RESISTANT COLORED MICROPARTICLES AND SKIN CARE COMPOSITIONS COMPRISING THEM | THE PROCTER & GAMBLE COMPANY (US) | 2007-12-13 | — | — | WO | disclosed |
| WO-2007141169-A1 | BLEED-RESISTANT COLORED MICROPARTICLES | CIBA HOLDING INC. (CH) | 2007-12-13 | — | — | WO | disclosed |
| US-20070286824-A1 | Bleed-resistant colored microparticles and skin care compositions comprising them | PROCTER & GAMBLE COMPANY, THE | 2007-12-13 | — | — | US | disclosed |
| EP-1765276-A1 | SHATTER RESISTANT ENCAPSULATED COLORANTS FOR NATURAL SKIN APPEARANCE | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2007-03-28 | — | — | EP | disclosed |
| WO-2005123009-A1 | SHATTER RESISTANT ENCAPSULATED COLORANTS FOR NATURAL SKIN APPEARANCE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-12-29 | — | — | WO | disclosed |
| US-20050276774-A1 | Shatter resistant encapsulated colorants for natural skin appearance | CIBA CORPORATION | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190040172-A1 | AQUEOUS EMULSION POLYMERS AS RHEOLOGY MODIFIERS, COMPOSITIONS THEREOF, AND METHOD OF USE | MUC1, ACP1, F12 | TSHR 3382/4885CPB2 3808/4885CYP1A2 4511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.